[1]尚红,王毓三,申子瑜.脑脊液化学检验.全国临床检验操作规程,2015:180.[2]万学红,卢雪峰.脑脊液监测,诊断学(第8版),2013:324.[3]王琳,牛爱军,王开森,孙晓,胡成进. 脑脊液免疫球蛋白在中枢神经系统疾病中的临床应用[J]. 放射免疫学杂志,2013,05:647-648.[4]吉国泰,孙鸣,王昌铭,彭昌鼎. 脑囊虫病治疗前后脑脊液IgA含量分析[J]. 实用医药杂志,2002,04:267.[5]沈壮虹,汪利平,林红. 脑脊液免疫球蛋白与C-反应蛋白对感染性脑膜炎老年患者临床诊断的价值[J].中华医院感染学杂志,2016,03:586-588.[6]何宇平.中枢神经系统肿瘤脑脊液免疫球蛋白测定的临床意义[J].河北医学,1997(01):29-30.[7]江慧珊.结核性脑膜炎的护理管理研究进展[J].心理月刊,2020,15(01):237[8]Westman G,Sohrabian A,Aurelius E,Ahlm C,Schliamser S,Sund F,Studahl M, R?nnelid J.Clinical significance of IgM and IgA class anti-NMDAR antibodies in herpes simplex encephalitis.J Clin Virol.2018,103:75-80.[9]Tan Z,Zhou Y,Li X,Wang G,Tao J,Wang L,Ma Y,Li X.Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus.Clin Rheumatol.2018,37(1):227-233.[10]Kroth J,Ciolac D,Fleischer V,Koirala N, Kramer J,Muthuraman M,Luessi F,Bittner S,Gonzalez-Escamilla G,Zipp F,Meuth SG,Groppa S.Increased cerebrospinal fluid albumin and immunoglobulin A fractions forecast cortical atrophy and longitudinal functional deterioration in relapsing-remitting multiple sclerosis.Mult Scler.2019,25(3):338-343.
